Ultragenyx price target raised to $83 from $81 at Canaccord
Bullish setup: upside to target.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish setup: upside to target.
What happened, with direct paths to the underlying reporting
RARE received an analyst target update from Canaccord Genuity.
Target: $83
Posted price: $26.24
Analyst firm: Canaccord Genuity
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.